Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
出版年份 2020 全文链接
标题
Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
作者
关键词
Resiquimod, Thermosensitive liposomes, Immunotherapy, Breast cancer, αPD-1
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 330, Issue -, Pages 1080-1094
出版商
Elsevier BV
发表日期
2020-11-13
DOI
10.1016/j.jconrel.2020.11.013
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial
- (2019) Michael D. Gray et al. RADIOLOGY
- Clinical Trials of Thermosensitive Nanomaterials: An Overview
- (2019) Stefania Nardecchia et al. Nanomaterials
- Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study
- (2019) Cédric Thauvin et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Combining activatable nanodelivery with immunotherapy in a murine breast cancer model
- (2019) Azadeh Kheirolomoom et al. JOURNAL OF CONTROLLED RELEASE
- Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator
- (2019) Ruolin Lu et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-specific delivery of gemcitabine with activatable liposomes
- (2019) Samantha T. Tucci et al. JOURNAL OF CONTROLLED RELEASE
- Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles
- (2018) Ana Isabel Bocanegra Gondan et al. BIOMATERIALS
- Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
- (2018) Hyunjoon Kim et al. BIOMATERIALS
- Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery
- (2018) Wei-Lun Tang et al. BIOMATERIALS
- Recent advances in ultrasound-triggered therapy
- (2018) Chaopin Yang et al. JOURNAL OF DRUG TARGETING
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- Unique Photochemo-Immuno-Nanoplatform against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer
- (2018) Lu Zhang et al. NANO LETTERS
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy
- (2018) Melody Smith et al. OncoImmunology
- A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
- (2017) E J Cheadle et al. LEUKEMIA
- Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes
- (2017) Wei-Lun Tang et al. MOLECULAR PHARMACEUTICS
- T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
- (2017) Daniela Schmid et al. Nature Communications
- Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model
- (2017) Dong Gao et al. Journal of Cancer
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
- (2017) Carlene Petes et al. Frontiers in Immunology
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
- (2016) Nazila Kamaly et al. CHEMICAL REVIEWS
- Strategies for designing synthetic immune agonists
- (2016) Tom Y.-H. Wu IMMUNOLOGY
- A Simple and Improved Active Loading Method to Efficiently Encapsulate Staurosporine into Lipid-Based Nanoparticles for Enhanced Therapy of Multidrug Resistant Cancer
- (2016) Wei-Lun Tang et al. PHARMACEUTICAL RESEARCH
- Development of a spherically focused phased array transducer for ultrasonic image-guided hyperthermia
- (2016) Jingfei Liu et al. PHYSICS IN MEDICINE AND BIOLOGY
- Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
- (2016) Simon J. Dovedi et al. Oncotarget
- Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells
- (2016) S. J. Dovedi et al. Cancer Immunology Research
- A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice
- (2016) Gabriela Maria Wiedemann et al. OncoImmunology
- TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
- (2016) Thibaud Spinetti et al. OncoImmunology
- Current clinical trials testing the combination of immunotherapy with radiotherapy
- (2016) Josephine Kang et al. Journal for ImmunoTherapy of Cancer
- Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma
- (2015) I. Sagiv-Barfi et al. BLOOD
- CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery
- (2015) Azadeh Kheirolomoom et al. JOURNAL OF CONTROLLED RELEASE
- Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma
- (2015) Jiang Zhu et al. Journal of Hematology & Oncology
- Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model
- (2015) TAO YIN et al. Molecular Medicine Reports
- One Step Encapsulation of Small Molecule Drugs in Liposomes via Electrospray-Remote Loading
- (2015) Anthony D. Duong et al. MOLECULAR PHARMACEUTICS
- Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors
- (2015) Sebastian Schölch et al. Oncotarget
- Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
- (2015) R. L. Sabado et al. Cancer Immunology Research
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Toll-like receptors as therapeutic targets for cancer
- (2013) Johanna Holldack DRUG DISCOVERY TODAY
- Liposomal resiquimod for the treatment of Leishmania donovani infection
- (2013) K. J. Peine et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia
- (2013) Azadeh Kheirolomoom et al. JOURNAL OF CONTROLLED RELEASE
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
- (2012) S. J. Dovedi et al. BLOOD
- How can grafted breast cancer models be optimized?
- (2011) Séverine Mollard et al. CANCER BIOLOGY & THERAPY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
- (2011) Abbi L Engel et al. Expert Review of Clinical Pharmacology
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
- (2010) Yong Zhang et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway
- (2010) Li Xing et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12
- (2010) David A. Zaharoff et al. JOURNAL OF IMMUNOTHERAPY
- Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
- (2010) Azadeh Kheirolomoom et al. MOLECULAR PHARMACEUTICS
- Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: influence of ionic strength and osmotic pressure of the carrier liquid
- (2009) Stefan Hupfeld et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
- (2008) J. K. Miller et al. CANCER RESEARCH
- A review of stimuli-responsive nanocarriers for drug and gene delivery
- (2008) Srinivas Ganta et al. JOURNAL OF CONTROLLED RELEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started